TITLE

Ciprofloxacin versus Cefuroxime Axetil in the Treatment of Adult Patients with Acute Bacterial Sinusitis

AUTHOR(S)
Klein, Gerald L.; Whalen, Edward; Echols, Roger M.; Heyd, Allen
PUB. DATE
January 1998
SOURCE
Journal of Otolaryngology;Jan/Feb1998, Vol. 27 Issue 1, p10
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective: This study compared the use and efficacy of ciprofloxacin to cefuroxime axetil for adult patients with acute bacterial sinusitis. Method: We conducted a prospective, randomized, double-blind pilot study of oral ciprofloxacin (500 mg twice daily) versus cefuroxime axetil (250 mg twice daily) for 2 to 3 weeks in the treatment of adult patients with a clinical diagnosis of acute bacterial maxillary sinus infections or acute exacerbation of chronic bacterial sinusitis. Patients with microbiologically and radiologically confirmed sinusitis infection composed the efficacy population. Results: Of the 83 patients enrolled, 13 of 42 (31%) ciprofloxacin- and 19 of 41 (46%) cefuroxime axetil-treated patients had a respiratory pathogen isolated from a sinus aspirauon. The most frequent pretherapy isolates included Haemophilus influenzae (11), streptococcus species (20), staphylococcus species (7), Proteus mirabilis (3), and Neisseria sicca (3). At the end of therapy, clinical resolution or improvement in efficacy-valid patients was achieved in 12 (100%) ciprofloxacin-treated patients and in 14 (74%) cefuroxime axetil recipients. The five (26%) cefuroxime axetil clinical failures were due to development of superinfection. Bacteriologic eradication occurred in 12 (100%) and 14 (100%) ciprofloxacin and cefuroxime axetil patients, respectively. Similar clinical and bacteriologic response rates were observed at the 2- to 4-week follow-up. Among 83 intent-to-treat patients, 19 (45%) ciprofloxacin and 14 (34%) cefuroxime axetil patients had drug-related adverse events. The most common adverse event in both treatment groups was gastrointestinal. Conclusion: This pilot study suggests that ciprofloxacin is efficacious in the management of acute bacterial sinusitis.
ACCESSION #
23285054

 

Related Articles

  • Ciprofloxacin versus Cefuroxime Axetil in the Treatment of Acute Bacterial Sinusitis. Johnson, Peter A.; Rodriguez, Hector P.; Wazen, Jack J.; Huck, Werner; Shan, Michael; Tosiello, Robert; Heyd, Allen; Echols, Roger M. // Journal of Otolaryngology;Jan/Feb1999, Vol. 28 Issue 1, p3 

    Objective: This study was conducted to compare the efficacy and safety of ciprofloxacin to cefuroxime axetil for the management of acute bacterial sinusitis or acute exacerbations of chronic sinusitis. Method: In this prospective, multicentre, randomized, double-blind clinical trial, 501 adult...

  • Ciprofloxacin and Cefuroxime Axetil in Acute Community-Acquired Rhinosinusitis. Weis, M.; Hendrick, K.; Gravelle, K.; Tillotson, G. // Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p328 

    Compares the efficacy and tolerability of ciprofloxacin and cefuroxime axetil for treating acute rhinosinusitis. Methods; Results; Discussion.

  • The Infection-Free Interval: Its Use in Evaluating Antimicrobial Treatment of Acute Exacerbation... Anzueto, Antonio; Rizzo, John A.; Grossman, Ronald F. // Clinical Infectious Diseases;6/1/1999, Vol. 28 Issue 6, p1344 

    Comments on the articles of authors S. Chodos et al. that compared oral ciprofloxacin to clarithromycin and to cefuroxime axetil as therapy for acute bacterial exacerbation of chronic bronchitis (ABECB). Evaluation of antimicrobial agents for ABECB; Purpose of treating ABECB patients with...

  • Drug-induced linear IgA bullous dermatosis after discontinuation of cefuroxime axetil treatment. Pastuszczak, Maciej; Lipko-Godlewska, Sylwia; Jaworek, Andrzej K.; Wojas-Pelc, Anna // Journal of Dermatological Case Reports;2012, Vol. 6 Issue 4, p117 

    The article presents a case study on a 37-year-old woman who has pruritic bullous lesions which developed after her last dose of cefuroxime axetil. It provides a medical history of the patient who took cefuroxime axetil due to rhino-sinusitis. It offers information on linear lgA bullous...

  • Oral Adverse Reaction to Cefuroxime Axetil. Boras, V. Vucicevic; Brailo, V.; Juras, D. Vidovic; Hadzavdic, S. Ljubojevic; Panduric, D. Gabric // Annual Review & Research in Biology;2014, Vol. 4 Issue 15, p2471 

    A 62 year old female patient was referred to the Department of oral medicine due to the severe oral reaction two days after she started to use cefuroxime axetil. Buccal and sublingual mucosa was very inflamed and covered with thick pseudomembranes. Patient was otherwise healthy and did not take...

  • Simultaneous estimation of cefuroxime axetil and potassium clavulanate-analytical method development and validation. Ingale, Pramod L.; Dalvi, Sampada D.; Jadav, Deepali D.; Gudi, Sachin V.; Patil, Laxmileena D.; Kadam, Yogita A. // Der Pharma Chemica;2013, Vol. 5 Issue 5, p35 

    A simple, rapid and sensitive spectrophotometric method has been developed for simultaneous estimation of cefuroxime axetil and potassium clavulanate in combined dosage form. Maximum absorbance of cefuroxime axetil and potassium clavulanate was measured in methanol at 284 nm and 271nm. The...

  • Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults. Siegert, Ralf; Berg, Olof; Gehanno, Pierre; Leiberman, Alberto; Martinkenas, Jonas Laimutis; Nikolaidis, Paul; Arvis, Pierre; Alefelder, Melody; Reimnitz, Peter // European Archives of Oto-Rhino-Laryngology;Apr2003, Vol. 260 Issue 4, p186 

    In this multicentre, multinational, comparative, double-blind clinical trial, outpatients with both clinical signs and symptoms and radiographic evidence of acute sinusitis were randomly assigned to receive for 7 days either a twice-daily oral regimen of faropenem daloxate (300 mg) or a twice...

  • Cefuroxime axetil.  // Reactions Weekly;6/18/2011, Issue 1356, p11 

    The article describes the case of a 60-year-old woman who developed liver failure after receiving treatment with cefuroxime axetil for respiratory infection.

  • Twice-daily cefuroxime regimen is effective for pneumonia.  // Modern Medicine;Dec97, Vol. 65 Issue 12, p59 

    Presents an abstract of the study entitled `Sequential Therapy With Cefuroxime Axetil in Community-Acquired Pneumonia,' by P. Van den Brande, V. Vondra et al published in the August 1997 issue of the periodical `Chest.'

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics